Updates in melanoma: Treating BRAF and brain metastases

Bendamustine for indolent lymphoma reduces relapse after 10 years

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

T-VEC and checkpoint therapy for melanoma

Dacomitinib for EGFR positive lung cancer

Treating advanced melanoma with ipilimumab and HF10

Alectinib eclipses crizotinib for ALK positive lung cancer

Results from the APHINITY trial of two HER2 targeted agents with chemo

Treating BRCA breast cancer with PARP inhibition

Relieving spinal cord compression symptoms with a single radiation treatment

Nivolumab and ipilimumab for metastatic sarcoma

Dose escalation results of ceritinib and nivolumab for ALK NSCLC